Table 4.
Global description of the intervention doses in the 24 high schools participating in the PRALIMAP trial
| N | mean | standard deviation | median | Q1 | Q3 | min | max | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Education |
NPDA* |
year 1 |
24 |
9.0 |
3.5 |
8.3 |
6.6 |
12.5 |
3.4 |
13.9 |
| |
|
year 2 |
24 |
7.7 |
2.8 |
7.8 |
5.5 |
10.0 |
2.5 |
13.2 |
| |
PDA** |
year 1 |
12 |
8.2 |
1.9 |
7.8 |
7.3 |
9.3 |
4.7 |
11.8 |
| |
|
year 2 |
12 |
6.3 |
3.5 |
7.5 |
2.7 |
8.5 |
0.5 |
10.9 |
| Screening |
NPDA |
year 1 |
24 |
5.2 |
3.7 |
5.0 |
2.3 |
8.4 |
0.0 |
11.9 |
| |
|
year 2 |
24 |
5.0 |
3.4 |
5.4 |
1.8 |
7.9 |
0.0 |
10.1 |
| |
PDA |
year 1 |
12 |
6.3 |
3.5 |
6.6 |
3.1 |
9.3 |
1.2 |
10.8 |
| |
|
year 2 |
12 |
3.6 |
2.7 |
3.0 |
1.9 |
4.8 |
0.5 |
8.8 |
| Environment |
NPDA |
year 1 |
24 |
6.4 |
2.3 |
7.0 |
5.8 |
7.8 |
1.8 |
9.4 |
| |
|
year 2 |
24 |
5.7 |
2.0 |
6.1 |
4.6 |
7.3 |
1.2 |
9.6 |
| |
PDA |
year 1 |
12 |
7.8 |
1.8 |
7.6 |
6.8 |
8.4 |
5.2 |
12.5 |
| year 2 | 12 | 8.2 | 3.1 | 8.6 | 6.9 | 9.7 | 0.3 | 12.1 |
* NPDA : Non-programme-driven activities.
** PDA : Programme-driven activities.